Risk and surveillance of extraintestinal solid tumors in inflammatory bowel disease
10.3760/cma.j.cn101480-20221011-00163
- VernacularTitle:炎症性肠病肠外实性肿瘤的发生风险与监测
- Author:
Fuchao LI
1
;
Chenggong YU
1
Author Information
1. 南京大学医学院附属鼓楼医院消化内科，南京 210008
- Publication Type:Journal Article
- Keywords:
Inflammatory bowel disease;
Ulcerative colitis;
Crohn′s disease;
Extraintestinal tumors;
Lung cancer;
Thyoid carcinoma
- From:
Chinese Journal of Inflammatory Bowel Diseases
2022;06(4):293-298
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel disease (IBD) is a group of chronic non-specific intestinal inflammatory diseases mediated by multiple factors such as immune disorders, mainly including ulcerative colitis (UC) and Crohn′s disease (CD) . Malignant tumors are the second leading cause of death in IBD patients, including intestinal tumors and extraintestinal tumors. At present, the risk and related mechanism of extraintestinal tumors in IBD patients are still unknown. The study has found that the difference in the risk of extraintestinal tumors between UC and CD is also statistically significant. This article will outline the overall risk of extraintestinal tumors in IBD, and describe the risk, pathogenesis, and monitoring program of multi-system extraintestinal solid tumors in IBD, UC and CD, providing a theoretical basis for the prevention, surveillance and early diagnosis of extraintestinal tumors in IBD patients.
